Author(s): Carey JS, Laffan D, Thomson C, Williams MT
Abstract Share this page
Abstract The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer.
This article was published in Org Biomol Chem
and referenced in Medicinal Chemistry